A series of analogs of 1,25-dihydroxycholecalciferol and 25hydroxycholecalciferol were obtained with an additional hydroxyl in the aliphatic side chain at carbon atom C-24. These analogs were synthesized by direct and diastereoselective ␣-hydroxylation of enolates derived from respective vitamin D e
Convergent synthesis, chiral HPLC, and vitamin D receptor affinity of analogs of 1,25-dihydroxycholecalciferol
✍ Scribed by Małgorzata Odrzywolska; Michał Chodyński; Sebastian J. Halkes; Jan-Paul Van De Velde; Hanna Fitak; Andrzej Kutner
- Publisher
- John Wiley and Sons
- Year
- 1999
- Tongue
- English
- Weight
- 136 KB
- Volume
- 11
- Category
- Article
- ISSN
- 0899-0042
No coin nor oath required. For personal study only.
✦ Synopsis
A series of analogs of 1,25-dihydroxycholecalciferol was obtained with an additional chiral center at the terminus of the aliphatic side chain (C-25). The analogs were obtained from (+)-(R)-and (-)-(S)-2-methylglycidols, by opening of the oxirane ring with the carbanions derived from vitamin D C 23a,24 -or C 22 -sulfones. The diastereomeric purity of the analogs was determined by high-performance liquid chromatography on a chiral stationary phase. The binding affinity of analogs for the calf thymus intracellular vitamin D receptor (VDR) was two orders of magnitude lower than that of the lead compound of this group, 24a,24b-dihomo-1,25-dihydroxycholecalciferol, and it was comparable to the affinity of analogs of 24-nor-1,25-dihydroxycholecalciferol. However, a twofold difference was observed for analogs diastereomeric at C-25 in their affinity for VDR. The diastereodifferentiation of the binding affinity was found to be specific for vitamin D vicinal 25,26-diols as it disappears for analogs where 26-hydroxyl, neighboring the C-25 chiral center, is replaced with methyl.
📜 SIMILAR VOLUMES
## Abstract Exposure of leukemia cells to the physiologically active form of vitamin D~3~, 1,25‐dihydroxyvitamin D~3~ (1,25D~3~) normalizes their phenotype to cells that resemble mature monocytes. One of the earliest detectable events in this process is an upregulation of the nuclear receptor for 1
1,25-(OH) 2 D 3 (1,25) and 24,25-(OH) 2 D 3 (24,25) mediate their effects on chondrocytes through the classic vitamin D receptor (VDR) as well as through rapid membrane-mediated mechanisms, which result in both nongenomic and genomic effects. In intact cells, it is difficult to distinguish between g